Vytrus Biotech, S.A. (BME:VYT)
13.15
-0.05 (-0.38%)
Last updated: Nov 13, 2026, 1:21 PM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €98.94 million as of November 16, 2026. It is the 24,384th most valuable company in the world and the 141st biggest in Spain. Its market cap has increased by 65.41% in one year.
Market Cap
98.94M
Enterprise Value
95.98M
Revenue
10.00M
Global Rank
Country Rank
#141 Spain
PE Ratio
24.53
ChartMarket Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 98.94M, an increase of 543.80%. That is a compound annual growth rate of 49.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 98.94M | 53.80% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.96B |
| Laboratorios Farmaceuticos Rovi | 3.54B |
| Almirall | 2.33B |
| Faes Farma | 1.58B |
| Laboratorio Reig Jofre | 213.40M |
| Prim, S.A. | 211.75M |
| Atrys Health | 202.67M |
| Oryzon Genomics | 192.28M |